| Trademark Snap Shot Amendment & Mail Processing Stylesheet
(Table presents the data on Amendment & Mail Processing Complete) |
|||
|
OVERVIEW |
|||
| SERIAL NUMBER | 86293072 | FILING DATE | 05/28/2014 |
| REG NUMBER | 0000000 | REG DATE | N/A |
| REGISTER | PRINCIPAL | MARK TYPE | TRADEMARK |
| INTL REG # | N/A | INTL REG DATE | N/A |
| TM ATTORNEY | RINKER, ANTHONY MICHAE | L.O. ASSIGNED | 102 |
|
PUB INFORMATION |
|||
| RUN DATE | 01/23/2015 | ||
| PUB DATE | N/A | ||
| STATUS | 661-RESPONSE AFTER NON-FINAL-ACTION-ENTERED | ||
| STATUS DATE | 01/22/2015 | ||
| LITERAL MARK ELEMENT | DRIVER | ||
|
|
|||
| DATE ABANDONED | N/A | DATE CANCELLED | N/A |
| SECTION 2F | NO | SECTION 2F IN PART | NO |
| SECTION 8 | NO | SECTION 8 IN PART | NO |
| SECTION 15 | NO | REPUB 12C | N/A |
| RENEWAL FILED | NO | RENEWAL DATE | N/A |
| DATE AMEND REG | N/A |
|
|
|
FILING BASIS |
|||||
| FILED BASIS | CURRENT BASIS | AMENDED BASIS | |||
| 1 (a) | NO | 1 (a) | NO | 1 (a) | NO |
| 1 (b) | YES | 1 (b) | YES | 1 (b) | NO |
| 44D | NO | 44D | NO | 44D | NO |
| 44E | NO | 44E | NO | 44E | NO |
| 66A | NO | 66A | NO |
|
|
| NO BASIS | NO | NO BASIS | NO |
|
|
|
MARK DATA |
|
| STANDARD CHARACTER MARK | YES |
| LITERAL MARK ELEMENT | DRIVER |
| MARK DRAWING CODE | 4-STANDARD CHARACTER MARK |
| COLOR DRAWING FLAG | NO |
|
CURRENT OWNER INFORMATION |
|
| PARTY TYPE | 11-SUBSEQUENT OWNER BEFORE PUBLICATION |
| NAME | DRIVER GROUP, LLC |
| ADDRESS | 1700 OWENS ST, SUITE 200 SAN FRANCISCO, CA 94158 |
| ENTITY | 16-LTD LIAB CO |
| CITIZENSHIP | Delaware |
|
GOODS AND SERVICES |
|
| INTERNATIONAL CLASS | 005 |
| DESCRIPTION TEXT | Pharmaceutical preparations for the treatment of cancer |
| INTERNATIONAL CLASS | 035 |
| DESCRIPTION TEXT | Consulting, analysis and advisory services relating to business management and operations; consulting, analysis and advisory services relating to business management and operations in the fields of clinical pharmaceutical trials, pharmaceutical research and development, laboratory testing, and diagnostics |
| INTERNATIONAL CLASS | 036 |
| DESCRIPTION TEXT | Creation, operation and management of investment funds that invest in companies and entrepreneurs; private equity investment services; providing financing to companies and entrepreneurs; venture capital funding services; venture capital fund management; investment management; investment advisory services; investment consultation and advice; financial asset management; financial asset management consultation and advice; financial advisory services; financial research and analysis, namely, due diligence and selection services in the field of venture capital; financial services, namely, operation and management of hedge funds; hedge fund investment services |
| INTERNATIONAL CLASS | 042 |
| DESCRIPTION TEXT | Research and development of pharmaceutical preparations; laboratory research and testing services relating to gene sequencing-based tests; laboratory research and testing services relating to pharmaceuticals; consulting services in the fields of clinical pharmaceutical trials, pharmaceutical research and development, laboratory testing, and diagnostics; conducting clinical trials for others; compiling data for research purposes in the fields of gene sequencing, cancer research, and cancer treatment; providing an online, searchable database of research information relating to gene sequencing, cancer research, and cancer treatment; software as a services (SAAS) for use in extracting and analyzing data in the fields of gene sequencing, cancer research, and cancer treatment |
| INTERNATIONAL CLASS | 044 |
| DESCRIPTION TEXT | Medical testing for diagnostic or treatment purposes; Medical testing for diagnostic or treatment purposes in the field of cancer; Medical testing for diagnostic or treatment purposes featuring DNA sequencing |
|
GOODS AND SERVICES CLASSIFICATION |
|||||||
| INTERNATIONAL CLASS | 005 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
| INTERNATIONAL CLASS | 035 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
| INTERNATIONAL CLASS | 036 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
| INTERNATIONAL CLASS | 042 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
| INTERNATIONAL CLASS | 044 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
|
MISCELLANEOUS INFORMATION/STATEMENTS |
|
| CHANGE IN REGISTRATION | NO |
|
PROSECUTION HISTORY |
||||
| DATE | ENT CD | ENT TYPE | DESCRIPTION | ENT NUM |
| 01/22/2015 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | 010 |
| 01/21/2015 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | 009 |
| 01/21/2015 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | 008 |
| 09/10/2014 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | 007 |
| 09/10/2014 | GNRT | F | NON-FINAL ACTION E-MAILED | 006 |
| 09/10/2014 | CNRT | R | NON-FINAL ACTION WRITTEN | 005 |
| 09/10/2014 | DOCK | D | ASSIGNED TO EXAMINER | 004 |
| 08/27/2014 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | 003 |
| 06/10/2014 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 002 |
| 05/31/2014 | NWAP | I | NEW APPLICATION ENTERED IN TRAM | 001 |
|
CURRENT CORRESPONDENCE INFORMATION |
|
| ATTORNEY | Julia Huston, Esq. |
| CORRESPONDENCE ADDRESS | JULIA HUSTON, ESQ. FOLEY HOAG LLP 155 SEAPORT BLVD STE 1600 BOSTON, MA 02210-2600 |
| DOMESTIC REPRESENTATIVE | NONE |
|
PRIOR OWNER INFORMATION |
|
| PARTY TYPE | 10-ORIGINAL APPLICANT |
| NAME | Cancer Therapeutics Innovation Group, LLC |
| ADDRESS | Suite 14A 777 Third Avenue New York, NY 10017 |
| ENTITY | 16-LTD LIAB CO |
| CITIZENSHIP | Delaware |